Anavex Life Sciences Corp (AVXL)

[scottmiyadi]

LOOKING FORWARD: It’s all about the upcoming Rett readout later this month (& PDD to lesser extent); the whole Biogen BS debacle will perhaps play out in coming months to our advantage regarding AD. But it’s irrelevant for now is how I see it —- for now it’s all about Rett: we get to finally see what’s behind the curtain!! If MOA is proven I believe we will start seeing heady valuation gains as the market will then begin to price in our relevance for all the other indications (including AD) that show application to our sigma 1 approach. Hopefully by the time our AD data is ready sometime next year, Biogen will have flopped and the market will be hot for the next generation AD treatment.